Mankind Pharma

  • ID: 2500257
  • Company Profile
  • 5 Pages
  • India Business Reports
1 of 4
Started in 1995, Mankind Pharma has seen meteoric growth to become the seventh largest pharma company in domestic formulation sales in India. In 2011, the company recorded revenues of Rs 14bn. Its revenues have grown at a compounded rate of around 30% over the three year period FY08-11. Mankind is widely acclaimed as the top success story in Indian pharma over the last 10-15 years. Its rise has been meteoric. Mankind carved a niche for itself by targeting rural markets and slashing drug prices.

An aggressive sales force meticulously reached places where others couldn't, making it one of the fastest growing pharma company within a decade. This individual company focused reports provides you an in-depth understanding of its start, origin, strategic analysis of its businesses and operations. Additionally, it also provides the information on their manufacturing plants. This report will give you a complete and consolidated understanding of the business of the company, which is based on actual domestic formulation sales, as captured by a credible third party data company.

The report covers understanding of company's business based on therapeutic wise split of its sales for couple of years, its top brands, their size and the segment in which they operates. This will give pretty good idea of its domestic formulations business. With the help of this data, one can get the understanding of its domestic business strong and weak points.

In addition, last three years financial performance of the company has also been covered in this report. Not only has the last three years financial performance been included, but it has also been analysed (with key ratios been calculated) to give you insight into its financial health and strength & weaknesses from its financial health perspective. The financial performance analysis has been based on the audited statements and the actual filings done with the Government of India, thus it is quite credible. Finally, the report also covers the shareholding pattern / split / changes (if any) and the information on the promoters and the board of directors.
Note: Product cover images may vary from those shown
2 of 4
Corporate Information

Board of Directors

Shareholding Pattern

Business Information

Therapeutic Wise Sales Information

Sales Mix

Top Brands and their Sales

Financial Results for Last Three Years

Key Financial Ratios
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown